Ignacio Algarra

2.9k total citations
53 papers, 2.3k citations indexed

About

Ignacio Algarra is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ignacio Algarra has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Ignacio Algarra's work include Immune Cell Function and Interaction (34 papers), Immunotherapy and Immune Responses (28 papers) and T-cell and B-cell Immunology (20 papers). Ignacio Algarra is often cited by papers focused on Immune Cell Function and Interaction (34 papers), Immunotherapy and Immune Responses (28 papers) and T-cell and B-cell Immunology (20 papers). Ignacio Algarra collaborates with scholars based in Spain, Sweden and Belarus. Ignacio Algarra's co-authors include Federico Garrido, Ángel M. García‐Lora, Antonia Collado, José J. Gaforio, Teresa Cabrera, Francisco Ruiz‐Cabello, Irene Gallego Romero, María José Serrano, Laura Paco and M. Pérez and has published in prestigious journals such as The Journal of Immunology, Cancer Research and International Journal of Cancer.

In The Last Decade

Ignacio Algarra

53 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignacio Algarra Spain 24 1.5k 971 531 191 166 53 2.3k
Ángel M. García‐Lora Spain 27 1.6k 1.1× 1.2k 1.2× 699 1.3× 171 0.9× 175 1.1× 57 2.5k
Nanae Harashima Japan 27 982 0.7× 561 0.6× 752 1.4× 153 0.8× 146 0.9× 48 1.8k
Chuanlin Ding United States 25 2.1k 1.4× 562 0.6× 829 1.6× 310 1.6× 117 0.7× 54 3.2k
Anamika Bose India 26 1.0k 0.7× 619 0.6× 706 1.3× 176 0.9× 100 0.6× 87 1.9k
Karlheinz Friedrich Germany 31 1.0k 0.7× 1.1k 1.2× 1.4k 2.6× 425 2.2× 380 2.3× 78 3.2k
Aimin Jiang United States 27 1.6k 1.1× 673 0.7× 976 1.8× 237 1.2× 129 0.8× 53 2.6k
Witold Lasek Poland 19 675 0.4× 564 0.6× 415 0.8× 161 0.8× 111 0.7× 50 1.4k
Charles S. Tannenbaum United States 32 1.8k 1.2× 1.2k 1.2× 976 1.8× 295 1.5× 286 1.7× 59 2.9k
Mayumi Kawada Japan 16 466 0.3× 653 0.7× 644 1.2× 214 1.1× 127 0.8× 20 1.6k
Michael J. Brumlik United States 22 750 0.5× 570 0.6× 600 1.1× 64 0.3× 50 0.3× 35 1.7k

Countries citing papers authored by Ignacio Algarra

Since Specialization
Citations

This map shows the geographic impact of Ignacio Algarra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Algarra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Algarra more than expected).

Fields of papers citing papers by Ignacio Algarra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Algarra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Algarra. The network helps show where Ignacio Algarra may publish in the future.

Co-authorship network of co-authors of Ignacio Algarra

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Algarra. A scholar is included among the top collaborators of Ignacio Algarra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Algarra. Ignacio Algarra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Algarra, Ignacio, Federico Garrido, & Ángel M. García‐Lora. (2021). MHC heterogeneity and response of metastases to immunotherapy. Cancer and Metastasis Reviews. 40(2). 501–517. 17 indexed citations
2.
Romero, Irene Gallego, Cristina Garrido, Ignacio Algarra, et al.. (2018). MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy. Frontiers in Immunology. 9. 102–102. 24 indexed citations
3.
Romero, Irene Gallego, Cristina Garrido, Ignacio Algarra, et al.. (2014). T Lymphocytes Restrain Spontaneous Metastases in Permanent Dormancy. Cancer Research. 74(7). 1958–1968. 52 indexed citations
4.
Garrido, Federico, Ignacio Algarra, & Ángel M. García‐Lora. (2010). The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions. Cancer Immunology Immunotherapy. 59(10). 1601–1606. 74 indexed citations
5.
Paco, Laura, Ángel M. García‐Lora, Carmen Cabrera, et al.. (2007). Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response. International Journal of Cancer. 121(9). 2023–2030. 10 indexed citations
6.
García‐Lora, Ángel M., et al.. (2006). A new extract of the plant calendula officinalis produces a dual in vitroeffect: cytotoxic anti-tumor activity and lymphocyte activation. BMC Cancer. 6(1). 119–119. 145 indexed citations
7.
Algarra, Ignacio, et al.. (2004). The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunology Immunotherapy. 53(10). 904–10. 240 indexed citations
8.
Gaforio, José J., María José Serrano, Pedro Sánchez‐Rovira, et al.. (2003). Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen‐receptor status and predicts for poor prognosis. International Journal of Cancer. 107(6). 984–990. 95 indexed citations
9.
García‐Lora, Ángel M., Ignacio Algarra, Antonia Collado, & Federico Garrido. (2003). Tumour immunology, vaccination and escape strategies. European Journal of Immunogenetics. 30(3). 177–183. 45 indexed citations
10.
García‐Lora, Ángel M., et al.. (2003). MHC class I‐deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components. International Journal of Cancer. 106(4). 521–527. 67 indexed citations
11.
Algarra, Ignacio, E. Ortega, María José Serrano, Gerardo Álvarez de Cienfuegos, & José J. Gaforio. (2002). Suppression of splenic macrophageCandida albicansphagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice. FEMS Immunology & Medical Microbiology. 33(3). 159–163. 18 indexed citations
12.
Gaforio, José J., María José Serrano, Ignacio Algarra, E. Ortega, & Gerardo Álvarez de Cienfuegos. (2002). Phagocytosis of apoptotic cells assessed by flow cytometry using 7‐Aminoactinomycin D. Cytometry. 49(1). 8–11. 20 indexed citations
13.
Serrano, María José, et al.. (2002). Evaluation of a Gemcitabine‐Doxorubicin‐Paclitaxel Combination Schedule through Flow Cytometry Assessment of Apoptosis Extent Induced in Human Breast Cancer Cell Lines. Japanese Journal of Cancer Research. 93(5). 559–566. 19 indexed citations
14.
Algarra, Ignacio, Teresa Cabrera, & Federico Garrido. (2000). The HLA crossroad in tumor immunology. Human Immunology. 61(1). 65–73. 121 indexed citations
15.
Pedrinaci, Susana, Ángel M. García‐Lora, M. Pérez, et al.. (1999). Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma. International Journal of Clinical & Laboratory Research. 29(4). 166–173. 11 indexed citations
16.
Algarra, Ignacio, M. Pérez, María José Serrano, Federico Garrido, & José J. Gaforio. (1998). c-K-<i>ras</i> Overexpression Is Characteristic for Metastases Derived from a Methylcholanthrene-Induced Fibrosarcoma. 18(5-6). 261–270. 7 indexed citations
17.
Algarra, Ignacio, et al.. (1993). MHC class I expression on prelymphomatous and lymphomatous B-cells is not inhibited by an Eμ-myc transgene. European Journal of Cancer. 29(2). 238–241. 1 indexed citations
18.
Algarra, Ignacio, M. Pérez, Federico Garrido, et al.. (1993). Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue. International Journal of Cancer. 54(3). 518–523. 13 indexed citations
19.
Martı́n, Javier, José J. Gaforio, Ignacio Algarra, et al.. (1992). Effect of MHC class‐I transfection on local tumor growth and metastasis in an H‐2‐negative clone derived from a chemically induced fibrosarcoma. International Journal of Cancer. 52(1). 153–158. 6 indexed citations
20.
Pérez, M., Ignacio Algarra, Hans‐Gustaf Ljunggren, et al.. (1990). A weakly tumorigenic phenotype with high mhc class‐i expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma. International Journal of Cancer. 46(2). 258–261. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026